Elevating Precision Radiodiagnostics Beyond Patient Selection to Transform Clinical Decision-Making

11:30 am - Thursday 3rd December 2026

  • Demonstrating how molecular imaging can move beyond mechanistic understanding to directly influence treatment and surgical decision-making
  • Exploring how theranostic strategies can integrate targeted imaging and therapy to improve patient stratification and treatment precision
  • Assessing where targeted PET imaging may offer greater biological specificity than conventional metabolic imaging approaches such as FDG-PET

Speakers:

Group Chief Executive Officer & Chief Marketing Officer
PentixaPharm GmbH